ABSTRACT
Diet can not only provide nutrition for intestinal microbiota, it can also remodel them. However, is unclear whether and how diet affects the spread of antibiotic resistance genes (ARGs) in the intestinal microbiota. Therefore, we employed selected high-sugar, high-fat, high-protein, and normal diets to explore the effect. The results showed that high-sugar, high-fat, and high-protein diets promoted the amplification and transfer of exogenous ARGs among intestinal microbiota, and up-regulated the expression of trfAp and trbBp while significantly altered the intestinal microbiota and its metabolites. Inflammation-related products were strongly correlated with the spread of ARGs, suggesting the intestinal microenvironment after diet remodeling might be conducive to the spreading of ARGs. This may be attributed to changes in bacterial membrane permeability, the SOS response, and bacterial composition and diversity caused by diet-induced inflammation. In addition, acceptor bacteria (zygotes) screened by flow cytometry were mostly Proteobacteria, Firmicutes and Actinobacteria, and most were derived from dominant intestinal bacteria remodeled by diet, indicating that the transfer of ARGs was closely linked to diet, and had some selectivity. Metagenomic results showed that the gut resistance genome could be affected not only by diet, but by exogenous antibiotic resistant bacteria (ARB). Many ARG markers coincided with bacterial markers in diet groups. Therefore, dominant bacteria in different diets are important hosts of ARGs in specific dietary environments, but the many pathogenic bacteria present may cause serious harm to human health.
KEYWORDS: Diet, antibiotic resistance gene, inflammatory microenvironment, amplification and transfer, pathogenic bacteria
1. Introduction
The human gut is home to trillions of microorganisms and thousands of bacteria classes.1 There are six main categories and most are anaerobes.2 The number of bacteria in different regions of the intestine varies considerably. The ascending colon has the largest number of bacteria, followed by the terminal ileum (1011/g vs. 107–108/g), compared with no more than 102–103/g in the proximal ileum and jejunum. The host provides a suitable environment and sufficient nutrients for the intestinal microbiota, which in turn participates in the regulation of multiple functions of the body, such as affecting the growth and metabolism of the host, regulating the immune system, inhibiting the growth of pathogens, and maintaining the integrity of the intestinal barrier and the balance of the internal environment.3 In the process of shaping the intestinal microbiota, dietary changes can account for 57% of the differences in the intestinal microbiota, compared with 12% caused by gene changes, suggesting that diet plays a leading role in the formation of the intestinal microbiota.4 Western diets, which tend to be high-sugar and high-fat, can lead to metabolic disorders affecting the host gastrointestinal metabolism and immune balance.5 A protein-rich diet increases the activity of bacterial enzymes, such as β-glucuronidase, azo reductase, and nitroreductase, and produces toxic metabolites, which leads to inflammation.6 Therefore, diet is one of the most important environmental factors regulating the composition and function of the intestinal microbiota.
ARGs are increasingly prevalent in the environment, and have been found in water7 and food supply chains.8 Increasing amounts of ARGs such as Klebsiella pneumoniae carbapenemase (KPC-1) and New Delhi metallo-β-lactamase (NDM-1)-producing bacteria have been associated with multidrug resistance.9 Additionally, mcr-1-positive Enterobacteriaceae (MCRPE) have been found in food and environments in over 50 countries across four continents, and mcr-like elements have been detected in a variety of plasmid types including IncI2, IncHI2, and IncX4.10 More worrisome is extensive horizontal transfer of KPC-1,NDM-1 and mcr-1 in various Gram-negative bacteria, especially Escherichia coli and Klebsiella pneumoniae, which is accelerating the spreading of ARGs and badly compromising the treatment of infections, resulting in substantial morbidity and mortality.11 In addition, these ARGs can easily enter intestines along with water and food,12 where resident organisms can serve as potential receptor bacteria, and the appropriate temperature and rich nutrients in intestines are conducive to the reproduction and diffusion of ARB.13 Many studies have shown that there are many types of ARGs in intestines, and they can be transferred between intestinal microbiota through plasmids.14
One study found that horizontal gene transfer (HGT) is common in the human intestinal microbiota and occurs by various mechanisms, the most typical of which are transduction and conjugation transfer.15 Through conjugation transfer, many species in the same habitat can obtain ARGs, which are usually transferred across species boundaries.16 The high density of bacteria in the intestine can facilitate the transfer of plasmids between the same species or between different species.17 The high diversity of ARGs in human bacteria may lead to antibiotic resistance of human pathogens in the future. Once ARGs enter human pathogens, they may be transmitted to symbiotic bacteria through pathogens, then further spread among symbiotic bacteria, causing greater harm.18 In 2017, the World Health Organization published the first list of “priority pathogens” possessing antibiotic resistance.19 The list consists of 11 species, including Staphylococcus aureus, Helicobacter pylori, and Salmonella typhi. Eight of these can participate in DNA uptake through natural ability, and the three Enterobacteriaceae on the list potentially have this ability.20 Conjugation-mediated plasmid transfer may be the main reason to promote the emergence of highly pathogenic or antibiotic resistant pathogens.21 The main reason why they are considered represent a great threat to human health is that they can not only cause serious diseases, but are also resistant to currently effective antibiotics.
In addition to the risk of entering pathogenic bacteria, ARGs may also enter intestinal symbiotic bacteria, and ARGs may lie hidden in the intestinal microbiota for a long time. Even short-term use of antibiotics can leave ARGs in the human intestinal tract for several years.22 Some types of intestinal microbiota may be selected as receptor bacteria for further transmission after exogenous ARGs enter the intestine, and existing technology cannot successfully eradicate them.
The diet can not only provide energy for intestinal microbiota, it can also remodel them. However, there are few reports on whether and how diet affects the amplification and transfer of ARGs in the intestinal microbiota. The present study explored the effect of diet on the dissemination profiles of exogenous ARGs in the intestinal tract by analyzing the spatial and temporal characteristics of the colonization and transfer of ARGs, changes in the intestinal microbiota, membrane permeability, reactive oxygen species (ROS), the distribution of receptor bacteria, the types and quantities of intestinal resistance groups, and the correlation between ARGs and intestinal microbiota. The findings may help to provide a new approach for controlling the spread of ARGs.
2. Results
2.1. Diet alters the composition and metabolites of the intestinal microbiota in mice
High-sugar, high-fat, and high-protein diets could significantly alter the structure of the intestinal microbiota, and each diet had its own distribution patterns (Figure 1a). At the phylum level, Bacteroidetes was most dominant in the control group (51.55%), followed by the high-protein group (51.19%), the high-fat group (41.17%), and the high-sugar group (33.96%). Bacteroidetes and Firmicutes accounted for more than 96.98% in the control group, 93.03% in the high-protein group, 89.66% in the high-fat group, and 86.3% in the high-sugar group. In addition, Actinobacteria were more abundant in the high-sugar group (5.27%), while Verrucomicrobia were abundant in the high-fat group (2.90%), and Proteobacteria were abundant in the high-protein group (2.94%). At the genus level, in the high-sugar group, Bacteroides (16.00%) was the most abundant, followed by Blautia (5.03%), Enterococcus (4.87%), Mucispirillum (4.30%), Akkermansia (4.16%), and Alistipes (3.70%). In the high-fat group, Bacteroides (21.89%) was the most abundant, followed by Alistipes (6.61%), Mucispirillum (5.52%), Blautia (5.13%), and Akkermansia (3.21%). In the high-protein group, Bacteroides (16.94%) was dominant, followed by Romboutsia (7.59%), Alistipes (2.92%), Lactobacillus (1.64%), and Mucispirillum (1.18%). In the control group, the most abundant genus was Lactobacillus (2.76%), followed by Alistipes (2.33%) and Bacteroides (1.99%).
Principal coordinate analysis (PCoA) based on weighted UniFrac distance showed that some samples of high-sugar and high-fat diet communities coincided, and high-sugar, high-fat, and high-protein diet all diverged from the normal diet (Figure 1b). Based on LEfSe analysis, there were significant differences in bacteria among groups (bacterial biomarkers). The biomarkers were Enterococcus, Bacteroides, Lactococcus, Alistipes, Blautia, Erysipelatoclostridium, and Lachnoclostridium in the high-sugar group, but were Akkermansia, Parabacteroides, Lactococcus, Ruminococcus, Bifidobacterium, Escherichia, Helicobacter, and Streptococcus in the high-fat group. The high-protein group included Desulfovibrio, Clostridium, Bacteroides, Prevotella, Turicibacter, and Marvinbryantia. Finally, Parabacteroides, Ruminiclostridium, Lactobacillus, Eubacterium, and Lachnospiraceae were the markers in the normal group (Figure 1c). These results showed that the intestinal microbiota was significantly remolded by high-sugar, high-fat, and high-protein diets, compared with the normal diet, which indicates that a new intestinal microbiota may form to adapt to the dietary pattern.
Principal component analysis (PCoA) of metabolites revealed significant differences between the metabolites of high-sugar, high-fat, and high-protein diets and the control group (Figure 1d-e, Table 1). Analysis of specific metabolites showed that there were significant differences in some lipids, amino acids, and fatty acids, and many metabolites were associated with inflammation pathways. Furthermore, we assessed metabolites that may damage the intestinal mucosal barrier and cause inflammation, such as o-cresol, stearic acid, palmitic acid, indoxylsulfuric acid, acetamide, and 4-hexyloxyanilane, and proline, which were significantly higher in the high-sugar and high-fat groups than in the control group (p < .05). Compared with the control group, except for palmitic acid and 4-hexyloxyanilane (p > .05), the other metabolites associated with inflammation in the high-protein group were at significantly higher levels (p < .05). In addition, short chain fatty acids (SCFAs) including methylpentanoic acid, imidazoleacetic acid, 3-ureldopropionic acid, and γ-aminobutyric acid were detected, and SCFAs in the high-sugar and high-fat groups were significantly lower than in the control group (p < .05). Except for γ-aminobutyric acid (p > .05), other SCFAs in the high-protein group were significantly less abundant than those in the control group (p < .05). In addition, several amino acids were analyzed, and levels of L-5-hydroxytryptophan and phenylalanine in the high-sugar, high-fat, and high-protein groups were significantly lower than those in the control group (p < .05). Tyrosine in the high-sugar and high-fat groups was significantly lower than in the control group (p < .05), and there was no significant difference compared with the high-protein group (Figure 1f).
Table 1.
Group | Df | Sums of squares | Mean squares | F Model | Variation (R2) | Pr |
---|---|---|---|---|---|---|
Control/Fat | 1 | 0.23758669 | 0.237587 | 8.297696 | 0.509133 | 0.004 |
Control/Sugar | 1 | 0.177125864 | 0.177126 | 7.343092 | 0.478593 | 0.006 |
Control/Protein | 1 | 0.177520284 | 0.17752 | 5.619834 | 0.412621 | 0.008 |
Fat/Sugar | 1 | 0.11402714 | 0.114027 | 6.691307 | 0.45546 | 0.008 |
Fat/Protein | 1 | 0.122816775 | 0.122817 | 5.011328 | 0.385151 | 0.009 |
Sugar/Protein | 1 | 0.090140785 | 0.090141 | 4.507848 | 0.360402 | 0.017 |
Df, degree of freedom.
R2, Contribution of a group to differences (the larger the R2, the greater the contribution).
Pr, p < .05 (high reliability).
Correlation analysis between bacteria with significant differences at the genus level and differential metabolites after comparing the high-sugar, high-fat, and high-protein groups with the control group respectively. The results showed that, in high-sugar group, Bacteroides, Enterococcus, Helicobacter, Ruminiclostridium, and Desulfovibrio were positively correlated with metabolites such as o-cresol, stearic acid, indoxylsulfuric acid, proline, and tryptophan, but were negatively correlated with SCFAs such as acetic acid, butyric acid, and propionic acid. High-fat and high-protein groups had similar correlation compared with the control group, and there was only difference in the strength of the correlation (Figure 1g).
2.2. Diet affects the temporospatial distribution of ARG amplification and transfer in the intestine
The temporal distributions of exogenous ARG amplification and transfer were monitored after long-term consumption of each diet. The diets were fed to remodel the intestinal microbiota of mice, and during ARB exposure for 7 days, the content of target ARGs in feces was continuously monitored. The results of real-time PCR showed that the patterns of all diets could be divided into three stages: a rising stage from 1–7 days, a declining stage from 8–23 days, and a stable stage after 25 days. All groups reached the peak value of 106 copies/g on the 7th day, then entered the declining stage after gavage, and continued to decline to ~102 copies/g, and maintained this level thereafter (Figure 2a). Comparing the differences between the three special diets and the control group revealed that the high-fat diet had a strong promoting effect on the amplification and transfer of ARGs, reaching 107 copies/g at the peak. From the first day to the 23rd day, amplification and transfer of ARGs was significantly higher in the high-fat diet group than the control group (p < .05), and there was no significant difference after the 23rd day (p > .05; Figure 2b). Levels of ARGs in the high-sugar group were significantly higher than in the control group from the 3rd day to the 19th day (p < .05), and there was no significant difference after the 19th day (p > .05) (Figure 2c). Amplification and transfer of ARGs in the high-protein group were significantly higher than in the control group from the 3rd day to the 17th day and the 21st day (p < .05), but there were no significant differences or other time points (p > .05) (Figure 2d). The results showed that high-sugar, high-fat, and high-protein diets could promote the amplification and transfer of exogenous ARGs in the intestine. The high-fat diet had the strongest and most long-lasting promoting effect, followed by the high-sugar diet and the high-protein diet.
We analyzed the expression of trfAp and trbBp during the three stages (rising, declining, and stable) under different diets. According to detection of the Trag gene in the fecal genome, we selected one time point for each of the three stages to measure expression of trfAp and trbBp. The results showed that in each diet group, expression of the genes in the rising stage was significantly higher than in the declining and stable phases (p < .001), and expression in the declining stage was also significantly higher than in the stable stage (p < .001). Expression of trfAp in the high-fat, high-sugar, and high-protein groups was significantly higher than that in the control group (p < .001). In the stable stage, there were no significant differences between groups (p > .05) (Figure 2e). Expression of trbBp in each diet group was similar to that of trfAp. In the rising stage, expression in the high-fat, high-sugar, and high-protein groups was significantly higher than in the control group (p < .001). In the declining stage, the high-fat and high-protein groups exhibited significantly higher expression levels than the control group (p < .01), but there was no significant difference between the high-sugar and control groups (p > .05). In the stable stage, there were no significant differences between the groups (p > .05) (Figure 2f). The results suggest that the effects of different diets on the conjugation and transfer of ARGs may be due to the regulation of gene expression, thereby promoting the conjugation and transfer of ARGs.
In order to further explore the spatial distribution of the above-mentioned exogenous ARGs in the gut, the intestinal tract was dissected when the ARGs in the feces of mice were stable, and the content of ARGs in each intestinal segment was determined by fluorescence quantitative PCR. The results showed that ARGs in the colon and cecum in the high-sugar group were significantly higher than in the small intestine (p < .001). ARGs in the cecum in the high-fat group were significantly more abundant than in the small intestine (p < .0001), and levels in the colon were higher than in the small intestine, but the difference was not significant (p > .05). ARGs in the cecum in the high-protein group were significantly higher than in the small intestine (p < .0001), and the colon (p < .05). ARGs in the cecum in the control group were significantly more abundant than in both the small intestine and the colon (p < .0001). In addition, ARGs in the small intestine were significantly higher in the high-sugar, high-fat, and high-protein groups than in the control group (p < .05). In the cecum, ARGs in high-sugar and high-fat groups were significantly higher than in the control group (p < .05), and the difference between high-protein and control groups was more significant (p < .01). In the colon, ARGs in high-sugar, high-fat, and high-protein groups were significantly higher than in the control group (p < .05; Figure 2g). The results showed that high-sugar, high-fat, and high-protein diets could promote the amplification and transfer of exogenous ARGs in all intestinal segments, among them, the cecum may be the main site for the amplification and transfer of ARGs.
Pearson correlation analysis of high-sugar, high-fat, and high-protein groups showed that levels of exogenous ARGs were significantly correlated with inflammatory markers, including serum immune factors, inflammatory-related metabolites, and inflammatory-related bacteria. Among them, pro-inflammatory factors, including interleukin 1β (IL-1β), IL-2, IL-6, and immunoglobulin G (IgG) and pro-inflammatory metabolites (o-cresol, indoxysulfuric acid, stearic acid, proline, etc.) and bacteria that destroy the intestinal mucosal barrier (Enterococcus, Clostridiales, Streptococcus, etc.) were positively correlated with levels of exogenous AGRs. The high-fat group had the highest positive correlation, followed by high-sugar and high-protein groups. Additionally, anti-inflammatory factors (IL-4, IL-10) and anti-inflammatory metabolites (methylpentanoic acid, imidazoleacetic acid, 3-ureldopropionic acid, γ-aminobutyric acid, phenylalanine), and bacteria that protect the intestinal mucosal barrier (Bifidobacterium, Akkermansia, and Lactobacter) were negatively correlated with levels of exogenous AGRs. The high-sugar group had the highest positive correlation, followed by high-fat and high-protein groups (Figure 2h-k). This suggests that inflammation may be related to the amplification and transfer of ARGs in the gut.
In order to further explore changes in bacterial structure and function occurring under a diet-induced inflammation microenvironment, we measured the cell membrane permeability of intestinal microbiota in each group by flow cytometry. Bacteria with damaged cell membranes in the normal diet group accounted for 14.6% of total bacteria, compared with 43.3% in the high-sugar group, 54.0% in the high-fat group, and 41.7% in the high-protein group (Figure 2l). Thus, high-fat, high-sugar, and high-protein diets can destroy the cell membrane and increase its permeability to a certain extent, which promotes plasmid conjugation and transfer. In addition, ROS produced in bacterial cells induced by diet can directly react with biomolecules, affecting cellular processes. The results showed that high-sugar, high-fat, and high-protein diets could significantly increase intracellular ROS. Compared with the control group, ROS levels in the high-sugar, high-fat and high-protein groups were 2.58-fold, 3.02-fold, and 1.52-fold higher, respectively (Figure 2m). The above results showed that the inflammatory microenvironment generated by high-fat, high-sugar, and high-protein diets can effectively stimulate bacteria to produce moderate levels of ROS and trigger the bacterial SOS response, thereby promoting plasmid conjugation and transfer. Finally, analysis of certain functional pathways related to plasmid conjugation and transfer showed that compared with the normal diet control group, more genes were enriched in these pathways in high-sugar, high-fat, and high-protein groups (Figure 2n). Among them, the high-fat group contained the most enriched genes, followed by high-sugar and high-protein groups. Therefore, the correlation between diet-induced inflammation and the transfer of ARGs may be reflected by the above aspects.
2.3. Diet affects the distribution of ARGs receptor bacteria
In order to identify receptor bacteria, mouse feces were collected 7 days after feeding donor bacteria, when the conjugation of ARGs with intestinal microbiota reached the maximum. Bacteria were sorted by flow cytometry for species identification. The results of flow cytometry showed that receptor bacteria (microbiota receiving exogenous ARGs) could be distinguished from the intestinal microbiota and gathered in a certain area (Figure 3a-d). The results of bacterial PCA showed that receptor bacteria for the four diets were clustered in a certain area, and there were large differences in the high-protein group. In each diet group, there is a certain distance between the distribution of receptor bacteria and dominant bacteria, with the high-sugar, high-fat, and high-protein groups closer, and the normal diet group further away. This shows that the dominant bacteria shaped by high-sugar, high-fat, and high-protein diets are more similar to their receptor bacteria than for the normal diet. In other words, the dominant bacteria shaped by high-sugar, high-fat, and high-protein diets are more likely to accept ARGs as receptor bacteria than those of the normal diet (Figure 3e).
Analysis of receptor bacteria at the phylum level showed that the receptor bacteria in each diet group mainly belonged to Proteobacteria, Firmicutes, Bacteroidetes, Actinobacteria, Acidobacteriata, Verrucomicrobia, Fusobacteriota, Deferibacters, and Myxococcota. Among them, Proteobacteria accounted for 58.68% in the high-sugar group, 53.43% in the high-fat group, 60.12% in the high-protein group, and 47.15% in the normal diet group (Figure 3f). These results suggest that Proteobacteria may be more likely to become a suitable host for RP4 plasmids carrying exogenous ARGs. Further analysis of receptor bacteria showed that those in the high-sugar diet group were mainly distributed in Lachnoclostridium, Mycobacterium, Enterococcus, Pseudoalleromonas, Sphingomonas, Aridibacter, Actinophytocola, Bacteroides, and Vibrio. In the high-fat diet group, receptor bacteria were mainly distributed in Defluviicoccus, Chthoniobacter, Enterococcus,Lactococcus, Bacillus, Akkermansia, and Ruminococ-cus. In the high-protein diet group, receptor bacteria were mainly distributed in Sporichthya, Vibrio, Enterococcus, Sphingomonas, Sphingomonas, Polaribacter, Tenacibaculum, Bacteroides, and Desulfovibrio. In the normal diet group, receptor bacteria were mainly distributed in Solirubrobacter, Mycobacterium, Vibrio, Ruminococcus, Lactobacillus, and Desulfovibrio (Figure 3g).
Compared with the dominant bacteria in the corresponding diet at the phylum level (top 10) and the genus level (top 35), some receptor bacteria present in high abundance in each diet group were the same as the dominant bacteria, indicating that some receptor bacteria came from the dominant bacteria. Bacteria in high-sugar, high-fat, and high-protein groups overlapping at the phylum level included Proteobacteria, Firmicutes, and Actinobacteria, while bacteria in the normal diet group overlapping at the phylum level were Proteobacteria, Firmicutes, and Deferribcteres. At the genus level, Lachnoclostridium, Enterococcus, Lactococcus, Ruminococcus, Bacteroides, and Acetobacter were common in the high-sugar group, while Akkermansia, Ruminococcus, Bacillus, Lactococcus, and Ruminococcus were common in the high-fat group, Lachnoclostridium, Desulfovibrio, Acetobacter, and Streptococcus were common in the high-protein group, and Lactobacillus, Desulfovibrio, Oscillibacter, and Mucispirillum were common in the normal diet group. In addition, the top 10 bacteria were counted at the phylum level, of which six species of donor bacteria and receptor bacteria were the same, accounting for 94% of total bacteria. The top 35 bacteria were counted at the genus level, of which 15 species of donor bacteria and recipient bacteria were the same, accounting for 68% of total bacteria. This shows that the dominant bacteria of each diet group are the main target for transfer of ARGs in this environment. This indicates that the dominant bacteria in the intestinal microbiota shaped by different diets can also become potential receptor bacteria. When donor and receptor bacteria are present in the same habitat, exogenous ARGs tend to be transferred not only to Proteobacteria, but also to the dominant bacteria in the different environment. And among these dominant bacteria, there are some probiotics (Lactobacillus, Bifidobacterium) and pathogenic bacteria (Streptococcus, Vibrio). This suggests that different diets play a guiding role in the selection of receptor bacteria by exogenous ARGs.
2.4. Diet affects the resistance genome of the intestinal microbiota
In order to analyze differences between diet groups, anosim analysis was conducted based on the abundance of ARGs. The results showed that there were significant differences between the high-sugar (S, p = .009), high-fat (F, p = .016), and high-protein (P, p = .012) groups and the normal diet group (C), indicating that different diets affected the intestinal resistance genome. Among them, the effect of the high-sugar diet was the most significant. There were significant differences between the high-sugar add ARB group (S-A, p = .003), the high-fat add ARB group (F-A, p = .015), the high-protein add ARB group (P-A, p = .017), and the normal diet add ARB group (C-A). Comparing the same diet with and without ARB revealed significant differences between the normal diet add ARB group (C-A) and the normal diet group (C; p = .013), the high-sugar diet add ARB group (S-A) and the high-sugar diet group (S; p = .012), and the high-protein diet add ARB group (P-A) and the high-protein diet group (P; p = .009). However, there was no significant difference between the high-fat diet add ARB group (P-A) and the high-fat diet group (P; p = .148; Figure 4a). Thus, based on different dietary effects, the addition of exogenous ARB may affect the intestinal resistance genome, with distinct characteristics for different treatments. Among them, the number of intestinal resistance genes increased significantly when exogenous ARB were added to the high-sugar, high-fat, and high-protein groups (Figure 4b). Classification of resistance genes showed that in the control group, tetracycline resistance genes were the most abundant, followed by β-lactam resistance genes. In the high-sugar group, tetracycline resistance genes were the most abundant, followed by macrolides and β-lactam resistance genes. In the high-fat group, tetracycline resistance genes were the most abundant, followed by β-lactam genes, and this was the same for the high-protein group. The abundance of multidrug resistance (MDR) genes was ordered high-sugar group, high-fat group, high-protein group, and control group, from high to low. After adding ARB, MDR genes were significantly increased in the S-A group and P-A group (Figure 4c).
In order to analyze the distribution of antibiotic resistance ontology (ARO) in each group, the top 30 ARO genes were selected to draw an abundance cluster heatmap (Figure 4d). The results showed that the ARO genes with the highest abundance in the high-sugar group were abcA, ErmF, vanSL, vanRG, cat86, tetX, and tetO. AAC6-lid, ANT6-la, ANT9-la, vanYA, vanRL, lsaE, lnuB, ErmB, FosA7, tetM, and tetL were the most abundant ARO genes in the high-sugar plus ARB group. The ARO genes with the highest abundance in the high-fat group were ANT4-lb, adeF, OXA-134, ErmF, tetQ, and tetX. TetQ, vanRG, and adeF were the most abundant ARO genes in the high-fat plus ARB group. The ARO genes with the highest abundance in the high-protein group were IMP-18, EreA2, tetQ, tetX, and tet36. AdeF, IMP-18, EreA2, and mdtP were the most abundant ARO genes in the high-protein plus ARB group. The ARO genes with the highest abundance in the normal diet group were blal, cat86, tetO, and tetW/N/W. AdeF, blal, cat-TC, mexH, and tetQ were the most abundant ARO genes in the normal diet adding ARB group.
The distribution of the above ARGs mainly included aminoglycosides, β-lactams, peptides, amphenicols, multidrug resistance genes, and tetracyclines. In addition, ARG markers were identified by absolute abundance analysis of ARGs in each diet group, revealing a high abundance of tetQ, adeF, tetW/N/W (absolute abundance >1000) and ErmF, tetX, tetO, and cat86 (absolute abundance between 1000 and 100) in each diet group before and after adding ARB. These results indicate that these resistance genes could be abundant in the intestinal microbiota in different diets with or without exogenous ARB, and were not affected by external factors. In addition, there were specific ARGs in different diets before and after adding exogenous ARB, such as abeM, cat-TC, vanYD, and cmrA in the normal diet add ARB group (C-A). In the normal diet group (C), gene marker was msrA. Gene markers in the high-sugar diet add ARB group (S-A) were ANT6-Ia, ANT9-Ia, lnuB, lsaE, vanYA, vanRL, mtrD, and oleD. Gene markers in the high-sugar diet group (S) were catV, salA, vanSI and arr-1. Gene markers in the high-fat diet add ARB group (F-A) were carA, mepA, rmtA, evgS, vanTN, Bla2 and kdpE. In high-fat diet group (F), gene markers were ANT4-Ib, OXA-134, lmrP, vanRD, vanXD, vanXYG, dfrC, EBR-1-β-lactamase, and cdeA. Gene markers adeS, chrB, MexK, APH2-IIa, Erm31, and MCR-4 were identified in the high-protein diet add ARB group (P-A). Gene markers in the high-protein diet group (P) were Erm41 and vanUG (Figure 4e). The above results showed that different diets can affect the distribution of ARGs, and the abundance of some specific ARGs can increase following consumption of different diets, implying that diet can shape the intestinal antibiotic resistance genome. Addition of exogenous ARB can further shape the intestinal antibiotic resistant genome following consumption of different diets.
Using the double circle diagram of the relationship between resistance genes and species, we further analyzed the species in which resistance genes were distributed in each group (Figure 4f). The results showed that ARO genes were mainly distributed in Firmicutes, Bacteroidetes, Proteobacteria, Chlamydiae, and Actinobacteria in the high-sugar group, and after adding ARB, Proteobacteria increased from 5% to 7%. ARO genes were mainly distributed in Firmicutes, Bacteroidetes, Proteobacteria, Chlamydiae, Actinobacteria, and Verrucomicrob-ia in the high-Fat group, and after adding ARB, Proteobacteria increased from 4% to 11%. In the high-protein group, ARO genes were mainly distributed in Firmicutes, Proteobacteria, Bacteroi-detes, Chlamydiae and Actinobacteria, and Proteobacteria increased from 6% to 9% after adding ARB. In the normal diet group, ARO genes were mainly distributed in Firmicutes, Bacteroidetes, Proteobacteria, Chlamydiae, Actinobacteria, and Candida melinabacter, and Proteobacteria increased from 3% to 9% after adding ARB. By counting the absolute number of these bacterial phyla that distribute ARGs, we found that although the number of Firmicutes was the highest, changes before and after ARB addition in each diet group were not consistent, and likewise for Bacteroidetes (Figure 4g-4i). Proteobacteria was significantly higher in all ARB-containing diet groups (C-A, S-A, F-A, P-A) than in non-ARB diet groups (C, S, F, P), and the abundance of Proteobacteria in the high-sugar, high-fat, and high-protein groups was significantly higher than in the normal diet group, among which the abundance of Proteobacteria in the high-protein group was the highest (Figure 4j).
2.5. Correlations between intestinal ARGs and bacteria in different diet groups
After adding ARB to each diet, the intestinal microbiota in high-sugar (p = .004), high-fat (p = .012), and high-protein (p = .008) groups were clustered together, and there were significant differences compared with the normal diet control group. The high-sugar add ARB group (p = .007), high-fat add ARB group (p = .012), and high-protein add ARB group (p = .041) were clustered together, and there were significant differences from the normal diet group. There was a significant difference between the high-fat add ARB group and the high-fat group (p = .028). There was a significant difference between the high-protein add ARB group and the high protein group (p = .008), but there was no significant difference between the high-sugar add ARB group and the high-sugar group (p = .083; Figure 5a). Therefore, the effect of diet on the intestinal microbiota was significantly greater than that of exogenous bacteria. In addition, there were significant differences in the distribution of the intestinal microbiota at the phylum level among diet groups before and after adding ARB (Figure 5b). Further analysis of the distribution of the top 30 bacteria at the genus level before and after adding ARB revealed a high abundance of Bacteroides, Ruminococcus, Clostridium, Eubacterium, and Alistipes in the normal diet group and the normal diet add ARB group. There was a high abundance of Bacteroides, Erysipelatoclostridium, Clostridium, Faecalibaculum, and Roseburia in the high-sugar group and the high-sugar add ARBgroup. Bacteroides, Erysipelatoclostridium, Clostridium, Akkermansia, and Parabacteroides were abundant in the high-fat group and the high-fat add ARB group. Bacteroides, Parabacteroides, Butyricimonas, Erysipelatoclostridium, Dorea, and Lactococcus were abundant in the high-protein group and the high-protein add ARB group (Figure 5c).
By analyzing the number of ARGs in different bacteria in each diet group, we found that Bacteroides, Alistipes, Parabacterioides, Clostridium, Chlamydia, Oscillibacter, and Eubacter possessed more ARGs in the C-A group. In the S-A group, Phascolarctobacterium, Enterococcus, Faecalibaculum, Eubacterium, Bacteroides, Oscillibacter, Clostridium, Lachnospira, and Chlamydia had more ARGs. In the F-A group, Bacteroides, Akkermansia, Phascolarctob-acterium, Parabacteroides, Lactococcus, Flavonifract-or, Chlamydia, and Erysipelatoclostridium harbored more ARGs. In the P-A group, Bacteroides, Parabacteroides, Clostridium, Prevotella, Chlamydia, Erysipelatoclostridium, and Phascolarctobacterium included more ARGs. In the C group, Alistipes, Clostridium, Bacteroides, Chlamydia, Eubacterium, Flavonifractor, and Merdimonas had more ARGs. In the S group, Bacteroides, Phascolarctobacterium, Erysipelatoclostridium, Enterococcus, Chlamydia, Lactococcus, and Clostridium possessed more ARGs. In the F group, Bacteroides, Parabacteroides, Erysipelatoclostridium, Escherichia, Enterococcus, Bacillus, and Phascolarctobacterium harbored more ARGs. In the P group, Bacteroides, Lactococcus, Chlamydia, Bacillus, Parabacteroides, Erysipelatoclos-tridium and Dorea included more ARGs. In conclusion, Bacteroide, Clostridium, Erysipelatoclostr-idium, and Enterococcus possessed more ARGs (Figure 5d).
Specific analysis of the distribution of ARGs in the corresponding bacteria in each group showed that Bacteroides had the most types and the highest number of ARGs. Therefore, symbiotic bacteria such as Bacteroides, which account for a large proportion of the intestinal microbiota, are more likely to become MDR bacteria. Some bacteria of Firmicutes are similar, such as Enterococcus and Lactococcus. They are abundant in the gut, hence they have a greater chance of receiving ARGs and becoming ARB. Some pathogenic bacteria were also identified, such as Chlamydia and Clostridium. Although Chlamydia contained the most different types of ARGs, the abundance of ARGs was not highest in these organisms. This indicates that the number of ARGs depends on the proportion of host bacteria in the intestine to a certain extent. In addition, Alistipes, Clostridium, and Eubacterium in group C and C-A, Phascolarctobacterium, Enterococcus, and Faecalibacum in group S and S-A, Akkermansia, Clostridium, and Lactococcus in group F and F-A, and Parabacteroides, Dorea, and Prevotella in group P and P-A had a high abundance of ARGs. This indicates that the dominant bacteria in different diets could be the main target for ARG colonization. Additionally, bacteria with a high abundance of ARGs were significantly increased after ARB addition to each diet group. Thus, invasion of exogenous ARB can disrupt the distribution of the original bacteria, allowing more members of the intestinal microbiota to accept ARGs and become new ARB. When considering groups before and after addition of ARB as a single group, Enterococcus, Faecalibaculum, and Phascolarctobacterium contained high abundance of ARGs in the high-sugar diet, Akkermansia, Escherichia, Flavonifractor, and Lactococcus contained a high abundance of ARGs in the high-fat diet, and Bacteroides, Parabcteria, Desulfovibrio, and Prevotella contained a high abundance of ARGs in the high-protein diet. In the normal diet, Clostridium, Alistipes, and Eubacterium contained a high abundance of ARGs (Figure 5e). These results suggest that bacteria remodeled by diet may be the main target of most ARGs in the gut.
These bacteria include intestinal symbiotic bacteria such as Bacteroides, Enterococcus, Ruminoco-ccus, Prevotella, Parabacterioides, Eubacterium, and Faecalibaculum, which can promote digestion and metabolism. Some can produce butyric acid, acetic acid, formic acid, and other beneficial SCFAs through fermentation. However, some are pathogenic. For example, Clostridium and Chlamydia can cause a variety of diseases, Escherichia can cause severe diarrhea, and Erysipelatoclostridium can cause severe infection. These results showed that when resistance genes select receptor bacteria, although they may be selective toward closely related bacteria or the dominant bacteria in the environment, symbiotic bacteria and pathogenic bacteria might not be distinguished. Because they are in the same niche, they may accept ARGs and become ARB, thereby inhibiting antibiotic treatment and representing a serious threat to human health.
3. Discussion
This study found that under the effect of various diets, the period during which exogenous ARGs enter the intestine can be divided into three stages: the rising stage, the declining stage, and the stable stage. In the rising stage, ARGs can reach ~106 copies/g; in the declining stage, levels drop continuously from 106 copies/g to 102 copies/g; in the stable stage, the content remains stable at ~102 copies/g. During the experiment, when the supply of exogenous ARB was stopped, exogenous ARGs gradually decreases to ~102 copies/g. Consistent with our observation, exogenous ARGs can proliferate and disseminate to indigenous gut microbiota via HGT, but the quantity of transconjugants in the gut declined to a lower level in the declining stage,13 which may be attributed to the fitness cost of plasmids. Although plasmids provide bacteria with new adaptive tools, they also entail a metabolic burden that, in the absence of selection for plasmid-encoded traits, reduces the competitiveness of the plasmid-carrying clone.23 Furthermore, there may be plasmid incompatibility between plasmids. The same negative feedback mechanism is used for the same types of plasmids. The more plasmids, the stronger the inhibition of replication, the slower the replication, and eventually many bacteria lose plasmids.24 This is why plasmids only exist in small numbers in the intestinal microbiota. However, when bacteria are placed under antibiotic selection pressure, plasmids can be quickly mobilized to replicate, and transferred to other bacteria through horizontal or vertical gene transfer to resist the threat of antibiotics. This may also be a strategy evolved by the intestinal microbiota to balance the contradiction between fitness cost and antibiotic pressure.
In addition, high-sugar, high-fat, and high-protein diets promote the amplification and transfer of ARGs in the intestine, which may be related to the inflammatory microenvironment caused by these three diets (Supplementary file S2). Evidence from experimental models suggests that although the intestinal microbiota usually drives immune activation, chronic inflammation in turn shapes the intestinal microbiota and leads to dysbacteriosis.25 High-sugar, high-fat, and high-protein diets can further activate the immune responses of regulatory T cells26 by affecting the intestinal microbiota and its metabolites,27 or stimulating the synthesis and secretion of toxic H2S, cresol, indole, and ammonia, which can increase intestinal permeability, damage intestinal cell DNA, interrupt intestinal cell metabolism and growth, and eventually lead to intestinal inflammation.28 Inflammation triggers the bacterial SOS response by producing many stressors29 (such as ROS), and promoting horizontal transfer of ARGs and the redistribution of virulence factors.17 Among these responses, moderate ROS production is conducive to increasing the frequency of junction transfer.30 In addition, high-sugar, high-fat, and high-protein diets may cause intestinal microbiota imbalance through inflammation, resulting in a decrease in colonization resistance of symbiotic bacteria,31 while the chances of donor and opportunistic bacteria engaging will increase significantly, thereby increasing the rate of ARG transfer. Under normal conditions, HGT between Enterobacteriaceae is blocked by symbiotic microbiota, mainly by maintaining the total density of facultative anaerobic bacteria at a fairly low level, ≪108 colony-forming units (CFU)/g,32 through colonization resistance of symbiotic microbiota. Following intestinal inflammation caused by diet, a transient outbreak of intestinal bacteria can occur,33 characterized by reduced diversity and increased abundance of some bacteria, causing a rapid acceleration in recombination and gene transfer. These outbreaks may facilitate the redistribution of plasmid-encoded genes between pathogens and symbionts, thereby increasing the suitability of plasmid-encoding and the transmission of determinants of ARGs.34 Additionally, environments with low diversity, with a simple microbiota composition but high abundance of specific taxa, are more conducive to the amplification and transfer of ARGs. Thus, high-sugar, high-fat, and high-protein diets may promote the amplification and transfer of ARGs through the interaction between the induced microbiota and its metabolites and the intestinal inflammatory microenvironment. Among them, the high-fat group showed the most severe inflammation, and therefore promoted the greatest amplification and transfer of ARGs, followed by the high-sugar and high-protein groups. This process can occur in all segments of the intestine, but mainly in the cecum and colon. The cecum is located between the small intestine and colon, which is the thickest, shortest, and most metabolically active part of the whole gut. The cecal bacterial concentration can be as high as 1011–1012 CFU/mL, hence it provides a base for receptor bacteria and a favorable place for bacterial conjugation and transfer. Because the small intestine is close to the stomach and the pH value is low, it is not conducive to the survival of bacteria, hence the bacterial content can be as low as 103–104 CFU/mL,35 and few receptor bacteria are available for conjugation and transfer. The amount of ARGs detected in different intestinal segments differs, mainly due to the intestinal structure and differences in the types and amounts of bacteria.
High-sugar, high-fat, and high-protein diets can significantly promote the amplification and transfer of ARGs. Furthermore, high-fat, high-sugar, and high-protein diets can promote the expression of regulatory genes trfAp and trbBp, which can stimulate the conjugation and transfer of ARGs. The trfAp gene encodes the initiation protein of plasmid replication, which can stabilize plasmid replication in many bacterial species.36 Also, trfAp is involved in the transmembrane transport and conjugation of plasmid DNA under the regulation of many operons. Conjugation requires cell-cell contact and the formation of conjugation pairs under the action of related regulatory genes.30 The protein encoded by the trbBp gene is responsible for processing and modifying the fimbriae on the cell surface, enabling cells to connect and build fimbriae protein channels, forming an efficient pairing system, and providing favorable conditions for DNA replication and transfer in the next step.37 Diet-induced inflammation led to changes in metabolic pathways in the intestinal microbiota, accompanied by changes in some gene functions. We analyzed several functions related to plasmid conjugation and transfer, including activating initiation protein (through similarity) involved in plasmid DNA replication, TrbL_Virb6 plasmid-binding transfer protein, the F pili assembly type IV secretion system for plasmid transfer, and plasmid-encoded RepA protein. We found that more genes were enriched in the high-fat, high-sugar, and high-protein groups than in the control group. This shows that in these diet groups, relatively more regulatory genes were mobilized to play a role in pathways related to plasmid conjugation and transfer, and thereby promote the transfer of ARGs. Therefore, increased expression of regulatory genes promoted by diet may induce the amplification and transfer of ARGs.
Following exogenous ARB carrying ARGs entering the intestine, the main receptor bacteria belong to Proteobacteria. In addition, we chose the RP4 plasmid carried by ARB, and directly administered it by gavage. The results showed that most of the RP4 plasmid was also enriched in Proteobacteria (Supplementary File S3). It is reported that carbapenems and extended spectrum agents work well against opportunistic E. coli and K. pneumoniae, while β-lactamase resistance genes are easily transmitted to Proteobacteria in the gut.38 In complex populations, even without selection pressure, distantly related bacteria can receive broad host range plasmids from donor bacteria.39 When broad host range plasmids (RP4) entered into complex communities, a core super-permissive fraction of the bacterial community can acquire plasmid from the donor strain, and Proteobacteria was the main hosts for broad host range plasmids,13,40,41 consistent with our results. It seems that Proteobacteria members are more likely to accept plasmids and maintain them in the latter stages. This may be because Proteobacteria strains have a unique ability to achieve efficient contact between cells through specific mating-mediating pheromones.42 In addition, analysis of the plasmid genomes and microbiome involvement of Proteobacteria revealed a large and highly diverse plasmid-encoded helper gene library, which is conducive to efficient binding and HGT,43 increasing the probability of plasmid uptake and conjugative transfer. Gene exchange is most frequent among bacteria of the same phylum, and most HGT (60%) occurs between closely related members of the same phylum.41 In this process, interactions between donor bacteria, receptor bacteria, and plasmids affect the transfer efficiency.44 Yano et al.45 reported that genetic differences between closely related IncP-1 plasmids through plasmid skeleton evolution can lead to significant differences in host range efficiency without affecting their broad host range properties. In addition, comparative analysis of plasmid sequences shows that the evolutionary host range of IncP-1a(RP4) plasmids seems to be mainly limited to Proteobacteria,46 and the fitness factors encoded by this plasmid are conducive to the growth of zygotes of Proteobacteria and the efficiency of the conjugation process.47
In our study, some high-abundance bacteria shaped by diet are also important hosts of ARGs. Examples include Enterococcus, Lactococcus, Ruminococcus, Bacteroides, Acetobacter in the high-sugar group. Akkermansia, Ruminococcus, Bacillus, and Lactococcus in the high-fat group; Lachnoclostridium, Desulfovibrio, Acetobacter, and Streptococcus in the high-protein group; and Lactobacillus, Desulfovibrio, Oscillibacter, and Mucispirillum in the normal diet group. Studies have shown that the same types of ARGs in different bacteria can be detected in a variety of environments, and their preference depends on the environmental niche.48 This shows that when bacteria in a specific environment share the same habitat with ARB, they have a greater chance of receiving drug-resistant genes and become new ARB. Therefore, ARGs are not random but selective in their host distribution. They may be preferentially shared between bacteria that are closely related, or transferred from bacteria strongly adapted to the same niche as a new host, which may be more conducive to transfer and expression at a lower fitness cost. Herein, different diet shaped own core super-permissive microbiota that could acquire ARGs from donor bacteria, and the microbiota comprised 68% of identified transconjungants.
With the development of metagenomics technology, we can not only determine the species and abundance of bacteria, but also analyze the distribution of ARGs in the whole intestinal microbiota resistance genome. The results of intestinal resistance genome analysis revealed more than 4 × 106 ARGs, and more than 20,000 known ARGs in the intestinal microbiota of the four diet groups. This shows that antibiotic abuse leads to the ubiquitous distribution of ARGs, and even specific pathogen-free (SPF) mice that have not been exposed to antibiotics can contain many ARGs, inherited from their mother or grandmother.49 The abundance of ARGs was analyzed, and genes related to tetracycline were the most abundant. Tetracycline is a broad-spectrum antibiotic that has been widely used since it was discovered in the 1940s. However, as tetracycline is widely used as a growth promoter and added to animal feed, the tolerance of bacteria to tetracycline is becoming stronger and stronger; in some areas, 66.9% of E. coli and 44.9% of Klebsiella are tetracycline resistant.50These results indicate that ARGs contaminating the environment may eventually accumulate in the intestines of animals. Different diets can further regulate the distribution of ARGs on this basis, and the high-sugar, high-fat, and high-protein groups contained significantly more ARGs than the control group. By comparing the distribution of ARGs in species before and after adding ARB, it was found that Proteobacteria increased significantly in each diet containing ARB group than in the corresponding ABR-free diet, suggesting that exogenous ARGs entered Proteobacteria easily. In addition, each group had a high abundance of Bacteroides, and Bacteroides contained the most different types and the highest abundance of ARGs. There are reports of ARGs in Bacteroides in different microecological environments.48 In addition, there were specific ARG markers in each diet group, and most were distributed among bacterial markers shaped by each diet, further proving that some dominant bacteria shaped by each diet can become important hosts of ARGs, demonstrating that the transfer of ARGs has a certain selectivity.
Although transfer of ARGs displays a certain selectivity between species, it seems that this selectivity does not include selection between symbiotic bacteria and pathogenic bacteria. In our current study, we found that the distribution of ARGs in these bacteria includes intestinal symbiotic bacteria, such as Bacteroides, Enterococcus, Ruminococcus, Prevotella, Parabacterioides, Eubacterium, Faecalibacum, and others. They not only promote digestion and metabolism, but also endow the host with multiple functions that promote immune homeostasis and immune responses, and prevent pathogen colonization.51 These functions include producing butyric acid, acetic acid, formic acid, and other beneficial SCFAs through fermentation. This may be beneficial for the colonization of symbiotic bacteria when ARGs enter symbiotic bacteria, by keeping the structure and abundance of the bacteria stable in the face of antibiotics and exogenous bacteria. However, it is also possible that they are transferred to other pathogenic bacteria. Some studies have reported that Lactobacillus carry ARGs and are resistant to antibiotics.51 Some may even transfer their inherent ARGs to other pathogens through HGT,52 thereby threatening human health. In addition, some ARGs are directly distributed in pathogenic bacteria, such as Clostridium and Chlamydia, which can cause a variety of diseases, and Escherichia and Erysipelatoclostridium, which are common in severe infections.53 Once the infection is rampant, it places a great burden on the host, and is difficult to treat due to the protective effects of ARGs. During clinical treatment, bacteremia patients infected with carbapenem-resistant Enterobacter-iaceae or carbapenem-resistant Pseudomonas aeruginosa suffer 40–70% mortality.54 Therefore, when selecting receptor bacteria, ARGs exhibit selectivity for bacteria that are close relatives and/or the dominant bacteria in the environment. However, symbiotic and pathogenic bacteria may not be distinguished because they occupy the same niche and may accept ARGs to become ARB, which may compromise the effects of antibiotic treatment and endanger host health. There is a potential risk associated with diets containing excessive nutrients such as high-sugar, high-fat, and high-protein diets. Therefore, when choosing diets, priority should be given to diets that protect the intestinal microbiota and intestinal health, such as those rich in dietary fiber.
In conclusion, the intestinal inflammatory microenvironment remolded by high-sugar, high-fat, and high-protein diets may be conducive to the spreading of ARGs, which mainly occurs in the cecum. Transfer of ARGs displays a certain selectivity for specific receptor bacteria, and tends to involve transfer to the dominant bacteria in a given dietary environment. Furthermore, depending on diet, exogenous ARGs can also alter the metagenomics and resistance genome of the intestines, representing a serious health threat.
4. Materials and Methods
4.1. Construction of fluorescent donor bacteria
The donor bacterium (MEC-5) isolated from mouse feces was identified as Escherichia coli. Donor strains were chromosomally tagged with mCherry encoding constitutive red fluorescence and the tac promoter expressing mCherry was encoded upstream.55 In addition, RP4 plasmids harboring tetracycline (tet) and kanamycin (km) resistance genes were appended to a genetically encoded expressible green fluorescent protein (GFP) gene. Next, MEC-5-mCherry was electroporated with the plasmid RP4-GFP-TetRKmR. As a result, both red and green fluorescence occurs in donor cells, but upon plasmid transfer to a fecal bacterium, the transconjugants display green fluorescence due to GFP expression, which can be detected and sorted by fluorescence microscopy or fluorescent-activated cell sorting (Supplementary File S1).
4.2. Animal experiments
Eight-week-old male SPF Balb/c mice (Beijing Weitonglihua Experimental Animal Company, Beijing, China) were fed for 1 week. Fresh feces were collected and antibiotic resistance of the intestinal microbiota was assessed using antibiotic-sensitive paper (Beijing SanYao Science and Technology Development Company, Beijing, China). The target plasmid was detected by agarose gel electrophoresis. Mice were divided into four groups: high-sugar diet (60%), high-fat diet (60 kcal%), high-protein diet (40%), and normal diet56 (Beijing Xiaoshuyoutai Biological Company, Beijing, China). After mice were fed different diets for 8 weeks to stabilize the inflammatory state, mice in each diet group whose intestinal microbiota had changed significantly were divided into experimental (gavaged with ARB) and blank control (gavaged with normal saline) groups. Mice in the ARB group were gavaged with 200 μL of bacterial solution (109 CFU/mL) once a day for 1 week. Mice in each experimental group (Plasmid groups) were gavaged with 200 μL of plasmid solution at a cell density of 109 CFU/mL, while mice in the control group were gavaged with the same amount of normal saline. After centrifugation at 3300 × g for 5 min, bacterial cells cultured overnight at 37°C were resuspended in normal saline, and the cell density was adjusted to 109 CFU per 200 μL. Mice were fed and watered freely, weighed once a week, and feces were collected and frozen for storage.
4.3. Quantitative PCR (qPCR) detection of target genes
Genomic DNA from fecal and intestinal samples were extracted using a Fecal Genome Extraction Kit (Qiagen, Dusseldorf, Germany). Primers were designed according to the Trag fragment of the RP4 plasmid-specific gene.13 A standard curve was drawn using plasmid standards, and target genes were detected by fluorescence qPCR. Total RNA was extracted from feces using a Total RNA Extraction Kit (Qiagen). RNA was reverse-transcribed into cDNA by a reverse transcription kit (Bao Bioengineering Company, Dalian, China), and fluorescence qPCR was performed to detect regulatory genes.
4.4. Separation of receptor bacteria by flow cytometry
Fecal suspensions were placed in an ultrasonic crusher for ~20 min before being passed through 70 μm and 10 μm filter screens. The bacterial suspensions were diluted to 105–106 cells with phosphate-buffered saline (PBS). Samples were analyzed in a flow cytometer (Bio-Rad ZE5, California, USA) equipped with a 488 nm laser. The green fluorescence was collected in the FITC channel (530 ± 15 nm). The red fluorescence was collected in the PE channel (585 ± 20 nm). After separating all bacterial liquids, samples were placed in centrifuge tubes containing 100 μL PBS (pH = 7.0) to collect green fluorescent bacteria for subsequent sequencing. To explore the mechanisms through which diet stimulates HGT, flow cytometry was employed to differentiate and quantify diet-exposed and control cells. Fluorescence intensity is a function of cell membrane permeability, with higher fluorescence intensity signifying enhanced cell membrane permeability. A 1 mL sample of bacterial suspension was stained with 10 μL of propidium iodide (PI, 1 mg/mL; OMEGA, Georgia, USA) and incubated in the dark for 8 min before measurement. The concentration of the bacterial suspension was always <106 cells/mL. The fluorescence intensity was measured at 488–525 nm.57 The reagent 2ʹ,7ʹ-dichlorofluorescein diacetate (DCFH-DA; Invitrogen, California, USA) was used to quantify intracellular ROS generation. Specifically, bacterial suspensions (106–107 CFU/mL) were stained by DCFH-DA (at a final concentration of 10 μM) for 20 min at 37°C in darkness. Bacterial suspensions were then washed by PBS, and the fluorescence intensity was measured at 488–525 nm to determine the generation of ROS by bacteria.30
4.5. Sequencing the intestinal microbiota
After genomic DNA was extracted from fecal samples using the cetyltrimethylammonium bromide method, the purity and concentration of DNA were determined and PCR amplification was performed. PCR products were analyzed by agarose gel electrophoresis and target bands were recovered. A DNA PCR Sample Preparation Kit (Illumina Truseq, San Diego, California, USA) was used to construct the library. After quantification by qubit (Thermo Fisher, Waltham, Massachusetts, USA) and qPCR, the quality of the library was determined, and the library was sequenced on a Novaseq 6000 Illumina system (Illumina Truseq). The original data were spliced with flash (v1.2.11, http://ccb.jhu.edu/software/FLASH/)58 to generate original tags, and clean tags were obtained by strictly filtering the raw data. Qiime (V2.0, http://qiime2.org/59) was employed for quality control. Tag sequences were compared with the species annotation database, and chimeric sequences were removed to generate the final valid tags (https://github.com/torognes/vsearch/). Uparse software (v7.0.100, http://www.drive5. com/uparse/) was used to cluster all valid tags of all samples (97%). The Mothur method in SILVA138 (http://www.arb-silva.de/)60 and the SSUrRNA database (threshold 0.8–1)61 was used to obtain taxonomic information for each taxonomic level and to determine the number of species in each sample community. Finally, data for each sample were normalized, and samples with the smallest amount of data were taken as the standard for normalization. Finally, α-diversity analysis and β-diversity were assessed based on normalized data.
4.6. Determination of intestinal metabolites
After tissue samples were ground in liquid nitrogen, 500 μL of 80% methanol water solution containing 0.1% formic acid was added. After vortex oscillation, samples were incubated in an ice bath for 5 min, then centrifuged at 15,000 × g and 4°C for 10 min. Part of each supernatant was diluted with mass spectrometry (MS)-grade water until the methanol content reached 53%, centrifuged in a centrifuge tube at 15,000 × g and 4°C for 10 min, and analyzed by liquid chromatography MS (LC-MS).62 Blank samples comprised 53% methanol water solution containing 0.1% formic acid, and the pretreatment process was the same as for treatment samples. The data file was imported into Compound Discoverer 3.1 (Thermo Fisher, Massachusetts, USA) for simple screening of retention time, mass charge ratio, and other parameters, and peaks in different samples were aligned according to a retention time deviation of 0.2 min and a mass deviation of 5 ppm to make the identification more accurate. The peak area was quantified, target ions were integrated, the molecular formula was predicted based on molecular ion peak and fragment ions, and compared with mzCloud (https://www.mzcloud.org/). Background ions were removed using data from blank samples, and quantitative results were normalized. Finally, data identification was achieved and quantitative results were obtained.
4.7. Metagenomics determination of the intestinal resistance genome
The concentration and purity of the fecal genome were determined using Qubit4 (Thermo, Massachus-etts, USA). Readfq (V8, https://github.com/cjfields/readfq) was used to preprocess the original data from the sequencing platform, and the preprocessed data were assembled and analyzed by SOAPdenovo software.63 The scaftigs generated by single sample and mixed assembly containing fragments <500 bp64 were filtered out. Metagenemark (V2.10, http://topaz.gatech.edu/GeneMark/) was used to predict the open reading frames (ORFs) of samples and scaftigs (≥500 bp),65 and fragments <100 nt were filtered out. Bowtie2 (Bowtie2.2.4) was used to compare the effective data for each sample with the initial gene catalog, and the number of reads in each sample was calculated. Genes with ≤2 reads in each sample were filtered out66 and the final gene catalog for subsequent analysis was obtained. Based on the number of reads and the gene length, the abundance of each gene in each sample was calculated. Based on the abundance of each gene in the gene catalog for each sample, basic statistics were derived. The resistance gene identifier software associated with the CARD database (https://card.mcmaster.ca/) was used to compare unigenes with the CARD database (RGI built-in blastp, default value ≤1e-30).67 According to the comparison of RGI values and the abundance of unigenes, antibiotic resistance ontology (ARO) was determined and analyzed.
4.8. Statistical analysis
GraphPad Prism V7.0 (https://www.graphpad.com/) and RStudio (https://www.rstudio.com/) were used for statistical analysis and mapping. Body weight, fecal excretion, and immune factors of mice in each group were analyzed by unpaired t-tests, Dunnett’s multiple comparison tests, or one-way analysis of variance (ANOVA) of Tukey’s multiple comparison tests. Statistical significance was set at 0.05, hence p > .05 means no statistical significance. The significance of pairwise comparisons is indicated by asterisks (*p < .05, **p < .01, ***p< .001). In α-diversity analysis, qiime software (v2.0, http://qiime2.org/) was used to calculate Chao1 and Shannon indices. Difference analysis of the α-diversity index between groups was conducted with parametric and nonparametric tests. Since the experiment involved more than two groups, Tukey and Wilcox tests were performed. For β-diversity, the ggplot2 (V4.05) program in the R software package (https://www.r-project.org/) was used to draw a principal coordinate analysis (PCoA) diagram, heatmap, and overview circle diagram. R software was used to analyze differences between groups for β-diversity, and parametric and nonparametric tests were carried out. The Anosim, MRPP, and Adonis functions of the R vegan package were also used.
Supplementary Material
Funding Statement
This work was supported by the key projects of National Natural Science Foundation of China [grant number 41831287], and the Tianjin Municipal Natural Science Foundation [grant number 19JCZDJC39900].
Disclosure statement
No potential conflict of interest was reported by the author(s).
Data availability
All data used to support the results of this study, including macrogenome data (bioproject ID: prjna753725) and 16S sequencing data (bioproject ID: prjna718065), have been uploaded to NCBI.
Supplementary material
Supplemental data for this article can be accessed on the publisher’s website.
References
- 1.Thursby E, Juge N.. Introduction to the human gut microbiota. Biochem J. 2017;474(11):1823–23. doi: 10.1042/BCJ20160510. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 2.Eckburg PB, Bik EM, Bernstein CN, Purdom E, Dethlefsen L, Sargent M, Gill SR, Nelson KE, Relman DA. Diversity of the human intestinal microbial flora. Science. 2005;308(5728):1635–1638. doi: 10.1126/science.1110591. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 3.Barrett HL, Gomez-Arango LF, Wilkinson SA, McIntyre HD, Callaway LK, Morrison M, Dekker Nitert M. A vegetarian diet is a major determinant of gut microbiota composition in early pregnancy. Nutrients. 2018;10(7):890. doi: 10.3390/nu10070890. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 4.Zhang C, Zhang M, Wang S, Han R, Cao Y, Hua W, Mao Y, Zhang X, Pang X, Wei C, et al. Interactions between gut microbiota, host genetics and diet relevant to development of metabolic syndromes in mice. ISME J. 2010;4(2):232–241. doi: 10.1038/ismej.2009.112. [DOI] [PubMed] [Google Scholar]
- 5.Sekirov I, Russell SL, Antunes LC, Finlay BB. Gut microbiota in health and disease. Physiol Rev. 2010;90(3):859–904. doi: 10.1152/physrev.00045.2009. [DOI] [PubMed] [Google Scholar]
- 6.Gorbach SL, Bengt E. Gustafsson memorial lecture. Function of the normal human microflora. Scand J Infect Dis Suppl. 1986;49:17–30. [PubMed] [Google Scholar]
- 7.Lupo A, Coyne S, Berendonk TU. Origin and evolution of antibiotic resistance: the common mechanisms of emergence and spread in water bodies. Front Microbiol. 2012;3:18. doi: 10.3389/fmicb.2012.00018. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 8.Rolain JM. Food and human gut as reservoirs of transferable antibiotic resistance encoding genes. Front Microbiol. 2013;4:173. doi: 10.3389/fmicb.2013.00173. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 9.Wang Y, Zhang R, Li J, Wu Z, Yin W, Schwarz S, Shen, J. Comprehensive resistome analysis reveals the prevalence of NDM and MCR-1 in Chinese poultry production. Nat Microbiol. 2017;2(4):16260. doi: 10.1038/nmicrobiol.2016.260. [DOI] [PubMed] [Google Scholar]
- 10.Wang C, Feng Y, Liu L, Wei L, Kang M, Zong Z. Identification of novel mobile colistin resistance gene mcr-10. Emerging Microbes Infect. 2020;9(1):508–516. doi: 10.1080/22221751.2020.1732231. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 11.Tse H, Yuen KY. Dissemination of the mcr-1 colistin resistance gene. Lancet Infect Dis. 2016;16(2):145–146. doi: 10.1016/S1473-3099(15)00532-0. [DOI] [PubMed] [Google Scholar]
- 12.Khan H, Miao X, Liu M, Ahmad S, Bai X. Behavior of last resort antibiotic resistance genes (mcr-1 and blaNDM-1) in a drinking water supply system and their possible acquisition by the mouse gut flora. Environ Pollut. 2020;259:113818. doi: 10.1016/j.envpol.2019.113818. [DOI] [PubMed] [Google Scholar]
- 13.Fu J, Yang D, Jin M, Liu W, Zhao X, Li C, Zhao T, Wang J, Gao Z, Shen Z, et al. Aquatic animals promote antibiotic resistance gene dissemination in water via conjugation: role of different regions within the zebra fish intestinal tract, and impact on fish intestinal microbiota. Mol Ecol. 2017;26(19):5318–5333. doi: 10.1111/mec.14255. [DOI] [PubMed] [Google Scholar]
- 14.Olekhnovich EI, Vasilyev AT, Ulyantsev VI, Kostryukova ES, Tyakht AV. MetaCherchant: analyzing genomic context of antibiotic resistance genes in gut microbiota. Bioinformatics. 2018;34:434–444. doi: 10.1093/bioinformatics/btx681. [DOI] [PubMed] [Google Scholar]
- 15.McInnes RS, McCallum GE, Lamberte LE, van Schaik W. Horizontal transfer of antibiotic resistance genes in the human gut microbiome. Curr Opin Microbiol. 2020;53:35–43. doi: 10.1016/j.mib.2020.02.002. [DOI] [PubMed] [Google Scholar]
- 16.Martinez JL. Bottlenecks in the transferability of antibiotic resistance from natural ecosystems to human bacterial pathogens. Front Microbiol. 2011;2:265. doi: 10.3389/fmicb.2011.00265. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 17.Diard M, Bakkeren E, Cornuault JK, Moor K, Hausmann A, Sellin ME, Loverdo C, Aertsen A, Ackermann M, De Paepe M, et al. Inflammation boosts bacteriophage transfer between Salmonella spp. Science. 2017;355:1211–1215. doi: 10.1126/science.aaf8451. [DOI] [PubMed] [Google Scholar]
- 18.Bengtsson-Palme J, Kristiansson E, Larsson DGJ. Environmental factors influencing the development and spread of antibiotic resistance. FEMS Microbiol Rev. 2018;42(1):68–80. doi: 10.1093/femsre/fux053. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 19.Tacconelli E, Carrara E, Savoldi A, Harbarth S, Mendelson M, Monnet DL, Pulcini C, Kahlmeter G, Kluytmans J, Carmeli Y, et al. Discovery, research, and development of new antibiotics: the WHO priority list of antibiotic-resistant bacteria and tuberculosis. Lancet Infect Dis. 2018;18(3):318–327. doi: 10.1016/S1473-3099(17)30753-3. [DOI] [PubMed] [Google Scholar]
- 20.Cameron AD, Redfield RJ. Non-canonical CRP sites control competence regulons in Escherichia coli and many other gamma-proteobacteria. Nucleic Acids Res. 2006;34:6001–6014. doi: 10.1093/nar/gkl734. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 21.Paulsen IT, Banerjei L, Myers GS, Nelson KE, Seshadri R, Read TD, Fouts DE, Eisen JA, Gill SR, Heidelberg JF, et al. Role of mobile DNA in the evolution of vancomycin-resistant enterococcus faecalis. Science. 2003;299(5615):2071–2074. doi: 10.1126/science.1080613. [DOI] [PubMed] [Google Scholar]
- 22.Jakobsson HE, Jernberg C, Andersson AF, Sjolund-Karlsson M, Jansson JK, Engstrand L. Short-term antibiotic treatment has differing long-term impacts on the human throat and gut microbiome. PloS One. 2010;5:e9836. doi: 10.1371/journal.pone.0009836. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 23.San Millan A, MacLean RC. Fitness costs of plasmids: a limit to plasmid transmission. Microbiol Spectr. 2017;5(5). doi: 10.1128/microbiolspec.MTBP-0016-2017. [DOI] [PubMed] [Google Scholar]
- 24.Huguet KT, Rivard N, Garneau D, Palanee J, Burrus V, Hughes D. Replication of the salmonella genomic Island 1 (SGI1) triggered by helper IncC conjugative plasmids promotes incompatibility and plasmid loss. PLoS Genet. 2020;16:e1008965. doi: 10.1371/journal.pgen.1008965. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 25.Ni J, Wu GD, Albenberg L, Tomov VT. Gut microbiota and IBD: causation or correlation? Nat Rev Gastroenterol Hepatol. 2017;14(10):573–584. doi: 10.1038/nrgastro.2017.88. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 26.Vipperla K, O’Keefe SJ. Diet, microbiota, and dysbiosis: a ‘recipe’ for colorectal cancer. Food Funct. 2016;7:1731–1740. doi: 10.1039/C5FO01276G. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 27.O’Keefe SJ. Diet, microorganisms and their metabolites, and colon cancer. Nat Rev Gastroenterol Hepatol. 2016;13:691–706. doi: 10.1038/nrgastro.2016.165. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 28.Toden S, Bird AR, Topping DL, Conlon MA. High red meat diets induce greater numbers of colonic DNA double-strand breaks than white meat in rats: attenuation by high-amylose maize starch. Carcinogenesis. 2007;28:2355–2362. doi: 10.1093/carcin/bgm216. [DOI] [PubMed] [Google Scholar]
- 29.Maier L, Diard M, Sellin ME, Chouffane ES, Trautwein-Weidner K, Periaswamy B, Slack E, Dolowschiak T, Stecher B, Loverdo C, et al. Granulocytes impose a tight bottleneck upon the gut luminal pathogen population during Salmonella typhimurium colitis. PLoS Pathog. 2014;10(12):e1004557. doi: 10.1371/journal.ppat.1004557. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 30.Cen T, Zhang X, Xie S, Li D. Preservatives accelerate the horizontal transfer of plasmid-mediated antimicrobial resistance genes via differential mechanisms. Environ Int. 2020;138:105544. doi: 10.1016/j.envint.2020.105544. [DOI] [PubMed] [Google Scholar]
- 31.Kachrimanidou M, Tsintarakis E. Insights into the role of human gut microbiota in clostridioides difficile infection. Microorganisms. 2020;8(2):200. doi: 10.3390/microorganisms8020200. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 32.Berg RD. The indigenous gastrointestinal microflora. Trends Microbiol. 1996;4(11):430–435. doi: 10.1016/0966-842X(96)10057-3. [DOI] [PubMed] [Google Scholar]
- 33.Winter SE, Thiennimitr P, Winter MG, Butler BP, Huseby DL, Crawford RW, Russell JM, Bevins CL, Adams LG, Tsolis RM, et al. Gut inflammation provides a respiratory electron acceptor for salmonella. Nature. 2010;467:426–429. doi: 10.1038/nature09415. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 34.Pfeifer Y, Cullik A, Witte W. Resistance to cephalosporins and carbapenems in gram-negative bacterial pathogens. Int J Med Microbiol. 2010;300(6):371–379. doi: 10.1016/j.ijmm.2010.04.005. [DOI] [PubMed] [Google Scholar]
- 35.Villmones HC, Halland A, Stenstad T, Ulvestad E, Weedon-Fekjaer H, Kommedal O. The cultivable microbiota of the human distal ileum. Clin Microbiol Infect. 2021;27:912 e7–e13 . doi: 10.1016/j.cmi.2020.08.021. [DOI] [PubMed] [Google Scholar]
- 36.Kostelidou K, Jagura-Burdzy G, Thomas CM. Mutational analysis of the global regulator KorA of broad-host-range plasmid RK2. J Mol Biol. 1998;281(3):453–463. doi: 10.1006/jmbi.1998.1956. [DOI] [PubMed] [Google Scholar]
- 37.Schreiner HC, Bechhofer DH, Pohlman RF, Young C, Borden PA, Figurski DH. Replication control in promiscuous plasmid RK2: kil and kor functions affect expression of the essential replication gene trfA. J Bacteriol. 1985;163:228–237. doi: 10.1128/jb.163.1.228-237.1985. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 38.Gottig S, Gruber TM, Stecher B, Wichelhaus TA, Kempf VA. In vivo horizontal gene transfer of the carbapenemase OXA-48 during a nosocomial outbreak. Clin Infect Dis. 2015;60:1808–1815. doi: 10.1093/cid/civ191. [DOI] [PubMed] [Google Scholar]
- 39.Shintani M, Matsui K, Inoue J, Hosoyama A, Ohji S, Yamazoe A, Nojiri H, Kimbara K, Ohkuma M. Single-cell analyses revealed transfer ranges of IncP-1, IncP-7, and IncP-9 plasmids in a soil bacterial community. Appl Environ Microbiol. 2014;80(1):138–145. doi: 10.1128/AEM.02571-13. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 40.Klumper U, Riber L, Dechesne A, Sannazzarro A, Hansen LH, Sorensen SJ, Smets BF. Broad host range plasmids can invade an unexpectedly diverse fraction of a soil bacterial community. ISME J. 2015;9(4):934–945. doi: 10.1038/ismej.2014.191. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 41.Kent AG, Vill AC, Shi Q, Satlin MJ, Brito IL. Widespread transfer of mobile antibiotic resistance genes within individual gut microbiomes revealed through bacterial Hi-C. Nat Commun. 2020;11(1):4379. doi: 10.1038/s41467-020-18164-7. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 42.Hirt H, Schlievert PM, Dunny GM. In vivo induction of virulence and antibiotic resistance transfer in enterococcus faecalis mediated by the sex pheromone-sensing system of pCF10. Infect Immun. 2002;70(2):716–723. doi: 10.1128/IAI.70.2.716-723.2002. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 43.Tenaillon O, Skurnik D, Picard B, Denamur E. The population genetics of commensal Escherichia coli. Nat Rev Microbiol. 2010;8(3):207–217. doi: 10.1038/nrmicro2298. [DOI] [PubMed] [Google Scholar]
- 44.Bingle LE, Zatyka M, Manzoor SE, Thomas CM. Co-operative interactions control conjugative transfer of broad host-range plasmid RK2: full effect of minor changes in TrbA operator depends on KorB. Mol Microbiol. 2003;49(4):1095–1108. doi: 10.1046/j.1365-2958.2003.03620.x. [DOI] [PubMed] [Google Scholar]
- 45.Yano H, Rogers LM, Knox MG, Heuer H, Smalla K, Brown CJ, Top EM. Host range diversification within the IncP-1 plasmid group. Microbiol (Reading). 2013;159(Pt_11):2303–2315. doi: 10.1099/mic.0.068387-0. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 46.Suzuki H, Yano H, Brown CJ, Top EM. Predicting plasmid promiscuity based on genomic signature. J Bacteriol. 2010;192(22):6045–6055. doi: 10.1128/JB.00277-10. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 47.Stecher B, Denzler R, Maier L, Bernet F, Sanders MJ, Pickard DJ, Barthel M, Westendorf AM, Krogfelt KA, Walker AW, et al. Gut inflammation can boost horizontal gene transfer between pathogenic and commensal Enterobacteriaceae. Proc Natl Acad Sci U S A. 2012;109(4):1269–1274. doi: 10.1073/pnas.1113246109. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 48.Zeng J, Pan Y, Yang J, Hou M, Zeng Z, Xiong W. Metagenomic insights into the distribution of antibiotic resistome between the gut-associated environments and the pristine environments. Environ Int. 2019;126:346–354. doi: 10.1016/j.envint.2019.02.052. [DOI] [PubMed] [Google Scholar]
- 49.Parnanen K, Karkman A, Hultman J, Lyra C, Bengtsson-Palme J, Larsson DGJ, Rautava S, Isolauri E, Salminen S, Kumar H, et al. Maternal gut and breast milk microbiota affect infant gut antibiotic resistome and mobile genetic elements. Nat Commun. 2018;9(1):3891. doi: 10.1038/s41467-018-06393-w. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 50.Jones RN, Flonta M, Gurler N, Cepparulo M, Mendes RE, Castanheira M. Resistance surveillance program report for selected European nations. Diagn Microbiol Infect Dis. 2011[2014];78:429–436. doi: 10.1016/j.diagmicrobio.2013.10.008. [DOI] [PubMed] [Google Scholar]
- 51.Pickard JM, Zeng MY, Caruso R, Nunez G. Gut microbiota: role in pathogen colonization, immune responses, and inflammatory disease. Immunol Rev. 2017;279:70–89. doi: 10.1111/imr.12567. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 52.Devirgiliis C, Coppola D, Barile S, Colonna B, Perozzi G. Characterization of the Tn916 conjugative transposon in a food-borne strain of Lactobacillus paracasei. Appl Environ Microbiol. 2009;75:3866–3871. doi: 10.1128/AEM.00589-09. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 53.Milosavljevic MN, Kostic M, Milovanovic J, Zaric RZ, Stojadinovic M, Jankovic SM, Stefanovic SM. Antimicrobial treatment of Erysipelatoclostridium ramosum invasive infections: a systematic review. Rev Inst Med Trop Sao Paulo. 2021;63:e30. doi: 10.1590/s1678-9946202163030. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 54.Satlin MJ, Walsh TJ. Multidrug-resistant Enterobacteria-ceae, Pseudomonas aeruginosa, and vancomycin-resistant Enterococcus: three major threats to hematopoietic stem cell transplant recipients. Transpl Infect Dis. 2017;19:e12762. doi: 10.1111/tid.12762. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 55.Mitsuhashi N, Kaneko M, D. M. Isolation of drug-resistant bacteria from newborn infants. Tohoku J Exp Med. 1977;121:77–80. doi: 10.1620/tjem.121.77. [DOI] [PubMed] [Google Scholar]
- 56.Tan R, Dong H, Chen Z, Jin M, Yin J, Li H, Shi D, Shao Y, Wang H, Chen T, et al. Intestinal microbiota mediates high-fructose and high-fat diets to induce chronic intestinal inflammation. Front Cell Infect Microbiol. 2021;11:654074. doi: 10.3389/fcimb.2021.654074. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 57.Xue Z, Sendamangalam VR, Gruden CL, Seo Y. Multiple roles of extracellular polymeric substances on resistance of biofilm and detached clusters. Environ Sci Technol. 2012;46(24):13212–13219. doi: 10.1021/es3031165. [DOI] [PubMed] [Google Scholar]
- 58.Magoc T, Salzberg SL. FLASH: fast length adjustment of short reads to improve genome assemblies. Bioinformatics. 2011;27(21):2957–2963. doi: 10.1093/bioinformatics/btr507. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 59.Bolyen E, Rideout JR, Dillon MR, Bokulich NA, Abnet CC, Al-Ghalith GA, Alexander H, Alm EJ, Arumugam M, Asnicar F, et al. Author Correction: reproducible, interactive, scalable and extensible microbiome data science using QIIME 2. Nat Biotechnol. 2019;37(9):1091. doi: 10.1038/s41587-019-0252-6. [DOI] [PubMed] [Google Scholar]
- 60.Edgar RC. UPARSE: highly accurate OTU sequences from microbial amplicon reads. Nat Methods. 2013;10:996–998. doi: 10.1038/nmeth.2604. [DOI] [PubMed] [Google Scholar]
- 61.Wang Q, Garrity GM, Tiedje JM, Cole JR. Naive bayesian classifier for rapid assignment of rRNA sequences into the new bacterial taxonomy. Appl Environ Microbiol. 2007;73:5261–5267. doi: 10.1128/AEM.00062-07. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 62.Mahmud I, Sternberg S, Williams M, Garrett TJ. Comparison of global metabolite extraction strategies for soybeans using UHPLC-HRMS. Anal Bioanal Chem. 2017;409:6173–6180. doi: 10.1007/s00216-017-0557-6. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 63.Luo R, Liu B, Xie Y, Li Z, Huang W, Yuan J, He G, Chen Y, Pan Q, Liu Y, et al. SOAPdenovo2: an empirically improved memory-efficient short-read de novo assembler. Gigascience. 2012;1(1):18. doi: 10.1186/2047-217X-1-18. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 64.Zeller G, Tap J, Voigt AY, Sunagawa S, Kultima JR, Costea PI, Amiot A, Böhm J, Brunetti F, Habermann N, et al. Potential of fecal microbiota for early-stage detection of colorectal cancer. Mol Syst Biol. 2014;10(11):766. doi: 10.15252/msb.20145645. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 65.Mende DR, Waller AS, Sunagawa S, Jarvelin AI, Chan MM, Arumugam M, Raes J, Bork P. Assessment of metagenomic assembly using simulated next generation sequencing data. PloS One. 2012;7(2):e31386. doi: 10.1371/journal.pone.0031386. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 66.Li J, Jia H, Cai X, Zhong H, Feng Q, Sunagawa S, Arumugam M, Kultima JR, Prifti E, Nielsen T, et al. An integrated catalog of reference genes in the human gut microbiome. Nat Biotechnol. 2014;32(8):834–841. doi: 10.1038/nbt.2942. [DOI] [PubMed] [Google Scholar]
- 67.Martinez JL, Coque TM, Baquero F. What is a resistance gene? Ranking risk in resistomes. Nat Rev Microbiol. 2015;13(2):1823–1836. doi: 10.1038/nrmicro3399. [DOI] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.
Supplementary Materials
Data Availability Statement
All data used to support the results of this study, including macrogenome data (bioproject ID: prjna753725) and 16S sequencing data (bioproject ID: prjna718065), have been uploaded to NCBI.